Zydus Lifesciences Limited (ZYDUSLIFE.BO)
INR 984.0
(0.5%)
INR 984.0
(0.5%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 8.04 Billion INR | -32.7% |
| 2023 | 11.94 Billion INR | -71.69% |
| 2022 | 42.2 Billion INR | -8.39% |
| 2021 | 46.07 Billion INR | -42.5% |
| 2020 | 80.13 Billion INR | 1.45% |
| 2019 | 78.99 Billion INR | 46.1% |
| 2018 | 54.06 Billion INR | 3.83% |
| 2017 | 52.07 Billion INR | 113.24% |
| 2016 | 24.42 Billion INR | -7.62% |
| 2015 | 26.43 Billion INR | -2.11% |
| 2014 | 27 Billion INR | -7.45% |
| 2013 | 29.17 Billion INR | 27.45% |
| 2012 | 22.89 Billion INR | 123.85% |
| 2011 | 10.22 Billion INR | -6.44% |
| 2010 | 10.93 Billion INR | -13.75% |
| 2009 | 12.67 Billion INR | 51.28% |
| 2008 | 8.37 Billion INR | 84.72% |
| 2007 | 4.53 Billion INR | 2.32% |
| 2006 | 4.43 Billion INR | 15.6% |
| 2005 | 3.83 Billion INR | -12.39% |
| 2004 | 4.37 Billion INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 FY | 8.04 Billion INR | -32.7% |
| 2024 Q1 | - INR | -100.0% |
| 2024 Q4 | 8.04 Billion INR | 0.0% |
| 2024 Q3 | - INR | -100.0% |
| 2024 Q2 | 1.91 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 11.94 Billion INR | -71.69% |
| 2023 Q4 | 11.94 Billion INR | 0.0% |
| 2023 Q2 | 24.46 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 42.2 Billion INR | 0.0% |
| 2022 FY | 42.2 Billion INR | -8.39% |
| 2022 Q2 | 46.79 Billion INR | 0.0% |
| 2021 Q2 | 56.43 Billion INR | 0.0% |
| 2021 Q4 | 46.07 Billion INR | 0.0% |
| 2021 FY | 46.07 Billion INR | -42.5% |
| 2020 Q4 | 80.13 Billion INR | 0.0% |
| 2020 FY | 80.13 Billion INR | 1.45% |
| 2020 Q2 | 70.82 Billion INR | 0.0% |
| 2019 Q2 | 52.5 Billion INR | 0.0% |
| 2019 FY | 78.99 Billion INR | 46.1% |
| 2019 Q4 | 78.99 Billion INR | 0.0% |
| 2018 Q2 | 48.71 Billion INR | 0.0% |
| 2018 Q4 | 54.06 Billion INR | 0.0% |
| 2018 FY | 54.06 Billion INR | 3.83% |
| 2017 Q2 | 27.11 Billion INR | 0.0% |
| 2017 FY | 52.07 Billion INR | 113.24% |
| 2017 Q4 | 52.07 Billion INR | 0.0% |
| 2016 Q4 | 24.42 Billion INR | 0.0% |
| 2016 FY | 24.42 Billion INR | -7.62% |
| 2016 Q2 | 20.16 Billion INR | 0.0% |
| 2015 Q2 | 22.37 Billion INR | 0.0% |
| 2015 Q4 | 26.43 Billion INR | 0.0% |
| 2015 FY | 26.43 Billion INR | -2.11% |
| 2014 Q4 | 27 Billion INR | 0.0% |
| 2014 Q2 | 29.46 Billion INR | 0.0% |
| 2014 FY | 27 Billion INR | -7.45% |
| 2013 FY | 29.17 Billion INR | 27.45% |
| 2013 Q2 | 22.07 Billion INR | 0.0% |
| 2013 Q4 | 29.17 Billion INR | 0.0% |
| 2012 Q4 | 22.89 Billion INR | 0.0% |
| 2012 FY | 22.89 Billion INR | 123.85% |
| 2011 FY | 10.22 Billion INR | -6.44% |
| 2010 FY | 10.93 Billion INR | -13.75% |
| 2009 FY | 12.67 Billion INR | 51.28% |
| 2008 FY | 8.37 Billion INR | 84.72% |
| 2007 FY | 4.53 Billion INR | 2.32% |
| 2006 FY | 4.43 Billion INR | 15.6% |
| 2005 FY | 3.83 Billion INR | -12.39% |
| 2004 FY | 4.37 Billion INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Ajanta Pharma Limited | 352.8 Million INR | -2179.478% |
| Amrutanjan Health Care Limited | 17.28 Million INR | -46431.274% |
| Sigachi Industries Limited | 1.43 Billion INR | -462.174% |
| Bal Pharma Limited | 1.39 Billion INR | -475.875% |
| Ind-Swift Laboratories Limited | 166.21 Million INR | -4738.283% |
| Medico Remedies Limited | 80.5 Million INR | -9889.566% |
| Lasa Supergenerics Limited | 220.76 Million INR | -3542.837% |
| Venus Remedies Limited | 413.3 Million INR | -1845.802% |
| Sun Pharma Advanced Research Company Limited | 611.5 Million INR | -1215.127% |
| Alpa Laboratories Limited | 52.46 Million INR | -15228.314% |
| Nectar Lifesciences Limited | 6.35 Billion INR | -26.539% |
| Shilpa Medicare Limited | 9.37 Billion INR | 14.208% |
| Aarti Drugs Limited | 5.64 Billion INR | -42.52% |
| Lupin Limited | 29.21 Billion INR | 72.476% |
| Aurobindo Pharma Limited | 66.47 Billion INR | 87.902% |
| Windlas Biotech Limited | 36.41 Million INR | -21987.339% |
| Suven Life Sciences Limited | 7.09 Million INR | -113215.485% |
| Eris Lifesciences Limited | 27.81 Billion INR | 71.085% |
| Valiant Laboratories Limited | 767.08 Million INR | -948.386% |
| J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | -112.943% |
| Solara Active Pharma Sciences Limited | 10.11 Billion INR | 20.494% |
| Ipca Laboratories Limited | 14.38 Billion INR | 44.089% |
| Bliss GVS Pharma Limited | 998.4 Million INR | -705.488% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 75.434% |
| Bajaj HealthCare Limited | 3.32 Billion INR | -141.629% |
| RPG Life Sciences Limited | - INR | -Infinity% |
| Mankind Pharma Limited | 2.07 Billion INR | -288.179% |
| Laurus Labs Limited | 25.77 Billion INR | 68.798% |
| Piramal Pharma Limited | 47.1 Billion INR | 82.926% |
| Syncom Formulations (India) Limited | 724.86 Million INR | -1009.446% |
| Torrent Pharmaceuticals Limited | 40.22 Billion INR | 80.005% |
| Alembic Pharmaceuticals Limited | 5.13 Billion INR | -56.715% |
| Glenmark Pharmaceuticals Limited | 12.3 Billion INR | 34.667% |
| Unichem Laboratories Limited | 2.47 Billion INR | -224.911% |
| Sequent Scientific Limited | 4.87 Billion INR | -64.899% |
| Novartis India Limited | 69.7 Million INR | -11438.02% |
| Wanbury Limited | 1.16 Billion INR | -590.392% |
| Suven Pharmaceuticals Limited | 649.96 Million INR | -1137.299% |
| Wockhardt Limited | 23.56 Billion INR | 65.866% |
| Themis Medicare Limited | 957.92 Million INR | -739.526% |
| Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -8894.52% |
| Jubilant Pharmova Limited | 36.64 Billion INR | 78.051% |
| Glenmark Life Sciences Limited | 171.48 Million INR | -4589.76% |
| Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 59.83% |
| Divi's Laboratories Limited | 30 Million INR | -26706.667% |
| NATCO Pharma Limited | 3.71 Billion INR | -116.649% |
| Gufic Biosciences Limited | 3.32 Billion INR | -141.563% |
| IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | -2354.823% |
| Ind-Swift Limited | 10.13 Billion INR | 20.69% |
| Procter & Gamble Health Limited | 95.6 Million INR | -8312.134% |
| FDC Limited | 205.18 Million INR | -3819.39% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | -315.759% |
| Granules India Limited | 13.15 Billion INR | 38.847% |
| Medicamen Biotech Limited | 308.17 Million INR | -2509.582% |
| Alkem Laboratories Limited | 14.18 Billion INR | 43.303% |
| AstraZeneca Pharma India Limited | 45.98 Million INR | -17389.452% |
| Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -183130.804% |
| Brooks Laboratories Limited | 56.41 Million INR | -14154.063% |
| Megasoft Limited | 1.47 Billion INR | -446.9% |
| ZIM Laboratories Limited | 1.08 Billion INR | -638.989% |
| Strides Pharma Science Limited | 25.16 Billion INR | 68.048% |
| Neuland Laboratories Limited | 953.89 Million INR | -743.069% |
| Morepen Laboratories Limited | 289.99 Million INR | -2673.18% |
| Hikal Limited | 8.17 Billion INR | 1.637% |
| Indoco Remedies Limited | 6.71 Billion INR | -19.68% |
| Aarti Pharmalabs Limited | 2.85 Billion INR | -181.928% |
| Kilitch Drugs (India) Limited | 316.46 Million INR | -2441.197% |
| Mangalam Drugs & Organics Limited | 984.92 Million INR | -716.509% |
| Hester Biosciences Limited | 2.44 Billion INR | -229.08% |